Enhertu 100mg Injection

About this medicine

Enhertu 100mg Injection (Trastuzumab Deruxetecan)is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.

Enhertu 100 mg Injection is an advanced prescription biologic developed by AstraZeneca, used for the targeted treatment of HER2-positive cancers. It is primarily indicated for patients with metastatic or unresectable HER2-positive breast cancer, HER2-positive gastric cancer, and HER2-mutant non-small cell lung cancer. This medicine belongs to the class of antibody-drug conjugates. It combines a HER2-targeting monoclonal antibody with a potent chemotherapy payload. The antibody component binds specifically to HER2 receptors on tumor cells and delivers the cytotoxic agent directly into the cancer cells, leading to DNA damage and cell death. Enhertu is widely recognized for its strong clinical response in heavily pretreated patients and offers a focused mechanism of action that spares healthy tissue. It is administered under medical supervision in infusion centers and is part of many national and international cancer treatment protocols. At Macarius Health, we ensure reliable access to complex oncology medicines like Enhertu at competitive pricing to support better treatment outcomes.